Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.

Armijo LM, Wawrzyniec SJ, Kopciuch M, Brandt YI, Rivera AC, Withers NJ, Cook NC, Huber DL, Monson TC, Smyth HDC, Osiński M.

J Nanobiotechnology. 2020 Feb 18;18(1):35. doi: 10.1186/s12951-020-0588-6.

2.

Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort.

Mitchelmore PJ, Randall J, Bull MJ, Moore KA, O'Neill PA, Paszkiewicz K, Mahenthiralingam E, Scotton CJ, Sheldon CD, Withers NJ, Brown AR.

Thorax. 2017 Aug 26. pii: thoraxjnl-2016-209889. doi: 10.1136/thoraxjnl-2016-209889. [Epub ahead of print]

PMID:
28844058
3.

Iron Oxide Nanocrystals for Magnetic Hyperthermia Applications.

Armijo LM, Brandt YI, Mathew D, Yadav S, Maestas S, Rivera AC, Cook NC, Withers NJ, Smolyakov GA, Adolphi NL, Monson TC, Huber DL, Smyth HD, Osiński M.

Nanomaterials (Basel). 2012 May 7;2(2):134-146. doi: 10.3390/nano2020134.

4.

Zinc therapy for night blindness in cystic fibrosis.

Tinley CG, Withers NJ, Sheldon CD, Quinn AG, Jackson AA.

J Cyst Fibros. 2008 Jul;7(4):333-5. doi: 10.1016/j.jcf.2007.11.005. Epub 2008 Jan 8.

5.

Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection.

Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC.

Chest. 2002 Jan;121(1):48-54.

PMID:
11796431
6.

Smoking habits in a cohort of U.K. adolescents.

Withers NJ, Low JL, Holgate ST, Clough JB.

Respir Med. 2000 Apr;94(4):391-6.

7.

Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation.

Withers NJ, Rudkin ST, White RJ.

J Cardiopulm Rehabil. 1999 Nov-Dec;19(6):362-5.

PMID:
10609186
8.

The natural history of respiratory symptoms in a cohort of adolescents.

Withers NJ, Low L, Holgate ST, Clough JB.

Am J Respir Crit Care Med. 1998 Aug;158(2):352-7.

PMID:
9700106
9.

Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects.

Krishna MT, Madden J, Teran LM, Biscione GL, Lau LC, Withers NJ, Sandström T, Mudway I, Kelly FJ, Walls A, Frew AJ, Holgate ST.

Eur Respir J. 1998 Jun;11(6):1294-300.

Supplemental Content

Loading ...
Support Center